Clinical Trials Browser

Phase 3 × OTHER × atropine sulfate-diphenoxylate hydrochloride drug combination × Clear all

NCT07016737 2025-06-12

ESO-Nanjing12

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00583323 2014-08-21

Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET

Phase 3 Completed

Lymphoma